Bulletin of Experimental Biology and Medicine

, Volume 121, Issue 4, pp 339–340 | Cite as

Dopaminergic mechanisms in the immunostimulating effect of μ-opioid receptors

  • M. A. Cheido
  • G. V. Idova


Immunogenesis was appreciably stimulated in CBA mice injected the μ-opioid receptor agonist DAGO. This stimulation was prevented by transecting the pituitary peduncle. Immunoactivation induced by opioid peptide was due to interaction with the dopaminergic system, because the effect is canceled by preliminary haloperidol blocking of D2-postsynaptic receptors.

Key Words

μ-opioid receptors immunostimulation dopaminergic system 


  1. 1.
    L. V. Devoino and R. Yu. Il'yuchenok,Neurotransmitter Systems in Psychoneuroimmunomodulation. Dopamine, Serotonin, GABA, Neuropeptides [in Russian], Novosibirsk (1993).Google Scholar
  2. 2.
    G. V. Idova, M. A. Cheido, and L. V. Devoino,Zh. Mikrobiol., No. 2, 57 (1976).Google Scholar
  3. 3.
    M. A. Cheido and G. V. Idova,Fiziol. Zh.,79, No. 12, 18–22 (1993).Google Scholar
  4. 4.
    M. A. Cheido, G. V. Idova, and L. V. Devoino,Byull. Eksp. Biol. Med.,116, No. 9, 291–292 (1993).Google Scholar
  5. 5.
    J. H. Boublik and J. W. Funder,Eur. J. Pharmacol.,107, 11–16 (1985).CrossRefGoogle Scholar
  6. 6.
    J. L. Bussiere, M. W. Adler, and R. J. Rogers,Immunopharmacol. Immunotoxicol.,14, 657–673 (1992).PubMedGoogle Scholar
  7. 7.
    A. J. A. Cunningham,Nature,207, 1106 (1965).PubMedCrossRefGoogle Scholar
  8. 8.
    G. Di Chiara and A. Imperato,J. Pharmacol.,244, 1067–1080 (1988).Google Scholar
  9. 9.
    J. J. Feigenbaum, R. H. B. Fishman, and J. Yanai,Substance and Alcohol Actions/Misuse,3, 307–324 (1982).PubMedGoogle Scholar
  10. 10.
    Z. S. Herman, M. Huzarska, K. Kmieciak-Kolada, and J. Kowalski,Pharmacology,104, 106–112 (1991).Google Scholar
  11. 11.
    L. G. Latimer, P. Duffy, and P. W. Kalivas,J. Pharmacol. Exp. Ther.,241, 328–337 (1987).PubMedGoogle Scholar
  12. 12.
    A. S. Moskowitz and R. R. Goodman,J. Neurosci.,4, 1331–1342 (1984).PubMedGoogle Scholar
  13. 13.
    L. B. Nagy, J. Diamond, and A. Gordon,Proc. Nat. Acad. Sci. USA,85, 6973–6976 (1988).PubMedCrossRefGoogle Scholar
  14. 14.
    S. S. Negus, M. J. Picker, and A. Dykstral,J. Pharmacol. Exp. Ther.,256, No. 1, 148–158 (1991).Google Scholar
  15. 15.
    A. G. Robertson, H. Jackman, and H. Y. Meltzer,Psychiatry Res.,11, 353–364 (1984).PubMedCrossRefGoogle Scholar
  16. 16.
    P. Seeman and C. Ulpian,Adv. Exp. Med. Biol.,235, 55–63 (1988).PubMedGoogle Scholar

Copyright information

© Plenum Publishing Corporation 1996

Authors and Affiliations

  • M. A. Cheido
    • 1
  • G. V. Idova
    • 1
  1. 1.Institute of PhysiologySiberian Division of the Russian Academy of Medical SciencesNovosibirsk

Personalised recommendations